Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

UK science in line for £500m boost from EU

October 20, 2010 Research and Development UK Biobank, UKCMRI, biotech funding, life sciences, science parks

The European Investment Bank has unveiled a £500 million package of loans to boost the UK’s science and education base …
News
Dr Ben Goldacre

Dr Ben Goldacre: “This is a very broken system”

October 19, 2010 Medical Communications, Research and Development, Sales and Marketing Bad Science, Ben Goldacre, industry reputation, trial data

The pharma industry has its fair share of critics, but unfortunately for everybody, many are easy to dismiss – shrill, …
Feature

GSK collaborates on rare genetic diseases

October 19, 2010 Research and Development Fondazione San Raffaele, Fondazione Telethon, GlaxoSmithKline, Stem cells, gene therapy

GlaxoSmithKline has partnered with one of the biggest biomedical charities in Italy and the country’s largest private research institute to …
News

Bayer’s Xarelto hailed at Prix Galien

October 19, 2010 Research and Development Firazyr, Xarelto, prix galien

Bayer’s Factor Xa anticoagulant Xarelto scooped the Best Pharmaceutical Agent award at the prestigious Prix Galien ceremony. Xarelto is part …
News

Cutting-edge cancer treatments showcased at ESMO

October 18, 2010 Research and Development AstraZeneca, Boehringer, Cancer, Cancer Conference, Johnson & Johnson, Novartis, personalised medicine

The search for a ‘silver bullet’ against cancer has failed, for now, with the battle against the disease turning instead …
Feature

Sanofi signs translational research deal with Harvard

October 18, 2010 Research and Development Harvard, Sanofi-Aventis, academia, translational

Sanofi-Aventis is to collaborate on translational biomedical research with Harvard University in therapy areas such as cancer, diabetes and inflammation. …
News

Trial shows long-term benefits of Novartis’ Aclasta

October 18, 2010 Research and Development, Sales and Marketing Novartis, aclasta, osteoporosis

Novartis has published new data at the annual meeting of the American Society for Bone and Mineral Research in Toronto …
News

Roche investing $180m on US diagnostics facilities

October 18, 2010 Research and Development Diagnostics, Roche, Ventana, personalised medicine

Swiss drugmaker Roche is planning to invest $180 million and boost staff at its diagnostics subsidiary Ventana Medical Systems, as …
News
Images of a normal brain and an Alzheimer's brain

Alzheimer’s disease

October 16, 2010 Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, Elan, J&J, JJ, Pfizer, lilly, pharmaceutical

In 1906 a psychiatrist working in a Frankfurt asylum became fascinated by the unnamed illness suffered by one of his …
Feature

Contract research news in brief

October 15, 2010 Research and Development Clinipace, Covance, PPD, Quintiles, Synexus, cellectis

Our latest crop of contract research news includes updates from Clinipace, PPD, Cellectis bioresearch, Covance, Quintiles and Synexus. US contract …
News

Celgene completes Abraxis takeover

October 15, 2010 Research and Development, Sales and Marketing Abraxane, Abraxis, Celgene, mergers and acquisitions, oncology

Celgene has completed its acquisition of Abraxis BioScience for cash and stock totalling $2.9 billion. The takeover gives the cancer …
News

Researchers unearth Pfizer’s buried data

October 14, 2010 Research and Development Ben Goldacre, Pfizer, publication, reboxetine, trial data

Researchers from Germany’s cost-effectiveness body IQWiG have unearthed a mountain of unpublished data from trials of Pfizer’s reboxetine that show …
News

Merck Serono eyes ‘Nanobody’ potential in rheumatology

October 14, 2010 Research and Development Ablynx, Merck Serono

Merck Serono has expanded its research with Ablynx and will co-develop ‘Nanobodies’ from the Belgian biotech against an inflammatory disease …
News

UK invests £50m in targeted research

October 13, 2010 Research and Development BIA, clinical research, genomics, personalised medicine, targeting

The government is to put more than £50 million of funding into a new initiative to produce more targeted research …
News

Philip Vickers joins Shire

October 13, 2010 Research and Development Shire, appointment, research and development

Shire has appointed Philip Vickers as senior VP of research and development for its Human Genetic Therapies (HGT) business. He …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025